Accès ouvert
2026
article
OpenAlex
Victor M Castro, Vivian Gainer, Nich Wattanasin, Andrew Cagan et autres
OBJECTIVE: Long COVID (LC) remains poorly understood, and there is a critical need for advanced computational tools to better identify and characterize patients. In this study, we use summarized symptom reports by RECOVER-Adult cohort participants linked to EHR data to characterize patients …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Leora I. Horwitz, Jacqueline Becker, Weixing Huang, Teresa Akintonwa et autres
Importance: Olfactory dysfunction is common after SARS-CoV-2 infection and has been associated with cognitive loss in other conditions. Formal testing is needed to characterize the presence, severity, and patterns of olfactory dysfunction. Objective: To characterize long-term olfactory dysfunction after SARS-CoV-2 infection. Design, …
us
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Dimpy P. Shah, Tanayott Thaweethai, Elizabeth W. Karlson, Hector Bonilla et autres
Importance: A substantial number of individuals worldwide experience long COVID, or post-COVID condition. Other postviral and autoimmune conditions have a female predominance, but whether the same is true for long COVID, especially within different subgroups, is uncertain. Objective: To evaluate sex differences …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Linda N. Geng, Kristine M. Erlandson, Mady Hornig, Rebecca Letts et autres
Importance: Classification of persons with long COVID (LC) or post-COVID-19 condition must encompass the complexity and heterogeneity of the condition. Iterative refinement of the classification index for research is needed to incorporate newly available data as the field rapidly evolves. Objective: To …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Zoe Swank, Ella Borberg, Yulu Chen, Yasmeen Senussi et autres
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Kristine M. Erlandson, Caitlin Selvaggi, Tanayott Thaweethai, Peter Chen et autres
BACKGROUND: There are currently no validated clinical biomarkers of postacute sequelae of SARS-CoV-2 infection (PASC). OBJECTIVE: To investigate clinical laboratory markers of SARS-CoV-2 and PASC. DESIGN: Propensity score-weighted linear regression models were fitted to evaluate differences in mean laboratory measures by prior …
us
(code pays fourni par la source)